Cargando…

HBV DNA suppression during entecavir treatment in previously treated children with chronic hepatitis B

The aim of this study was to assess HBV DNA suppression after 24 weeks of treatment with entecavir in previously treated children with CHB. Thirty children aged 5–17 years (25 males and 5 females) with CHB were treated with entecavir 0.5 or 1 mg daily. Twenty-two children were HBeAg-positive, eight...

Descripción completa

Detalles Bibliográficos
Autores principales: Pawłowska, M., Halota, W., Smukalska, E., Woźniakowska-Gęsicka, T., Kupś, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303069/
https://www.ncbi.nlm.nih.gov/pubmed/21796345
http://dx.doi.org/10.1007/s10096-011-1349-0